door wim | apr 20, 2022 | Uncategorized
Taipei (Taiwan)/ Enschede (the Netherlands), April 20, 2022. CEMMA Medical Company Limited – a leading company in the clinically advanced medical equipment market in Greater China – and the innovating Dutch biotech company LipoCoat BV today announced the...
door wim | mrt 29, 2022 | Uncategorized
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells® treatment for Traumatic Spinal Cord Injury Neuro-Cells® treatment aims to reduce irreversible damage to the central nervous system from secondary inflammation...
door wim | dec 14, 2021 | Uncategorized
Dutch stem cell biotech Neuroplast secures € 10 million (US$ 11.5 million) inSeries B funding to further advance its transformative stem cell therapy forTraumatic Spinal Cord Injury• € 10 million (US$ 11.5 million) raised to obtain conditional EMA market approval...
door wim | dec 14, 2021 | Uncategorized
Dutch stem cell biotech Neuroplast announces successful clinical Phase I trialwith its Neuro-Cells® stem cell treatment for Traumatic Spinal Cord Injury • Positive safety profile and well tolerated, without product-related adverse effects• Demonstrated clinical...
door wim | dec 14, 2021 | Uncategorized
ATRO Medical financing round 2021 Final ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis Nijmegen, 14 December 2021 Today ATRO Medical announces the successful closure of a €1,9 million financing round. The funding provided by a...
Recente reacties